Applied Therapeutics Inc. (APLT)
NASDAQ: APLT
· Real-Time Price · USD
0.48
-0.03 (-5.70%)
At close: Jul 25, 2025, 3:59 PM
Applied Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | -1K | 122K | 144K | 190K | -667K | n/a | n/a | 10.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 80K | n/a | 122K | 119K | 347K | 118K | 115K | n/a | 113K | 111K | 109K | 108K | 107K | 104K | 104K | 100K |
Gross Profit | n/a | -215K | 122K | 22K | 71K | -1.01M | -118K | -115K | 10.66M | -113K | -111K | -109K | -108K | -107K | -104K | -104K | -100K |
Operating Income | -25.52M | -33.02M | -29.74M | -20.44M | -21.09M | -21.01M | -15.49M | -17.18M | -10.86M | -18.97M | -19.36M | -21.52M | -23.1M | -27.11M | -28.43M | -25.88M | -24.2M |
Interest Income | 621K | 962K | 1.36M | 628K | 586K | 352K | 392K | 408K | 221K | 458K | 227K | 111K | 76K | n/a | 76K | 169K | n/a |
Pretax Income | -21.82M | 44.01M | -68.59M | 2.9M | -83.94M | -37.68M | -42.37M | -29.58M | -10.14M | -14.43M | -19.1M | -25.86M | -23.12M | -27.16M | -28.42M | -25.83M | -24.18M |
Net Income | -21.82M | 44.01M | -68.59M | 2.9M | -83.94M | -37.68M | -42.37M | -29.58M | -10.14M | -5.82M | -18.81M | -34.33M | -23.07M | -27.16M | -28.42M | -25.83M | -24.18M |
Selling & General & Admin | 17.69M | 21.25M | 15.04M | 10.58M | 9.07M | 5.04M | 4.71M | 5.29M | 5.58M | 6.88M | 6.24M | 6.13M | 8.07M | 11.39M | 10.83M | 11.07M | 9.75M |
Research & Development | 7.84M | 11.7M | 14.83M | 10M | 12.22M | 15.3M | 10.79M | 11.88M | 15.94M | 12.09M | 13.12M | 15.4M | 15.03M | 15.72M | 17.6M | 14.8M | 14.45M |
Other Expenses | n/a | 60K | n/a | -34K | -26K | -36K | 10K | -5K | n/a | 17K | -8K | -90K | -96K | n/a | -64K | -122K | -56K |
Operating Expenses | 25.52M | 33.02M | 29.86M | 20.46M | 21.28M | 20.34M | 15.49M | 17.18M | 21.52M | 18.97M | 19.36M | 21.52M | 23.1M | 27.11M | 28.43M | 25.88M | 24.2M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 721K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 555K | n/a | n/a | 76K |
Selling & Marketing Expenses | n/a | n/a | n/a | 127K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 25.52M | 33.02M | 29.86M | 20.58M | 21.28M | 20.34M | 15.49M | 17.18M | 21.52M | 18.97M | 19.36M | 21.52M | 23.1M | 27.11M | 28.43M | 25.88M | 24.2M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -118K | n/a | n/a | -8.61M | -291K | 8.47M | -56K | n/a | -76K | -169K | -76K |
Shares Outstanding (Basic) | 144.79M | 139.53M | 14.44M | 49.34M | 125.32M | 84.24M | 90.67M | 79.04M | 56.32M | 49.95M | 48M | 26.9M | 26.22M | 25.98M | 26.18M | 26.08M | 24.14M |
Shares Outstanding (Diluted) | 144.79M | 139.53M | 14.44M | 49.34M | 125.32M | 84.24M | 90.67M | 79.04M | 56.36M | 49.95M | 48M | 26.9M | 26.22M | 26.18M | 26.18M | 26.08M | 24.14M |
EPS (Basic) | -0.15 | 0.32 | -4.75 | 0.02 | -0.67 | -0.45 | -0.47 | -0.37 | -0.18 | -0.12 | -0.4 | -1.28 | -0.88 | -1.05 | -1.09 | -0.99 | -1 |
EPS (Diluted) | -0.15 | 0.32 | -4.75 | -0.13 | -1.7 | -0.45 | -0.47 | -0.37 | -0.18 | -0.12 | -0.4 | -1.28 | -0.88 | -1.04 | -1.09 | -0.99 | -1 |
EBITDA | -25.42M | -32.94M | -29.64M | -20.32M | -20.97M | -21M | -15.38M | -17.06M | -10.74M | -18.86M | -19.25M | -21.41M | -22.99M | -27.01M | -28.32M | -25.77M | -24.1M |
EBIT | -25.52M | -33.02M | -29.74M | -20.44M | -21.09M | -21.01M | -15.49M | -17.18M | -10.86M | -18.97M | -19.36M | -21.52M | -23.1M | -27.11M | -28.43M | -25.88M | -24.2M |
Depreciation & Amortization | 104K | 80K | 104K | 122K | 119K | 6K | 118K | 115K | 114K | 113K | 111K | 109K | 108K | 107K | 104K | 104K | 100K |